![Capecitabine 3-O-BDR Impurity (USP) ;3’-O-(5’-Deoxy-β-D-ribofuranosyl) Capecitabine ; [1-[5-Deoxy-3-O-(5-deoxy-β-D-ribofuranosyl)-β-D-ribofuranosyl]-5-fluoro-2-oxo-1,2-dihydropyrimidin-4-yl]-carbamic acid pentyl ester | 1262133-64-1](http://drjcrbio.com/wp-content/uploads/c-4c.png)
Capecitabine 3-O-BDR Impurity (USP) ;3’-O-(5’-Deoxy-β-D-ribofuranosyl) Capecitabine ; [1-[5-Deoxy-3-O-(5-deoxy-β-D-ribofuranosyl)-β-D-ribofuranosyl]-5-fluoro-2-oxo-1,2-dihydropyrimidin-4-yl]-carbamic acid pentyl ester | 1262133-64-1
Capecitabine 3-O-BDR Impurity (USP)
Description
| Code: JCCPB-11 |
| CAS: 1262133-64-1 |
| Chemical Formula: C20H30FN3O9 |
| Molecular Weight: 475.47 |
| Category: Reference Standards/API Drug Metabolites/EP Impurities/USP Impurities |
| Literature: |
| Application: Capecitabine 3-O-BDR Impurity (USP) ;3’-O-(5’-Deoxy-β-D-ribofuranosyl) Capecitabine ; [1-[5-Deoxy-3-O-(5-deoxy-β-D-ribofuranosyl)-β-D-ribofuranosyl]-5-fluoro-2-oxo-1,2-dihydropyrimidin-4-yl]-carbamic acid pentyl ester | 1262133-64-1 is useful as reference Impurity standard. |
